LAPADULA, Giuseppe
 Distribuzione geografica
Continente #
NA - Nord America 1.862
AS - Asia 764
EU - Europa 584
SA - Sud America 110
AF - Africa 11
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 3.336
Nazione #
US - Stati Uniti d'America 1.836
CN - Cina 317
SG - Singapore 249
DE - Germania 144
UA - Ucraina 140
BR - Brasile 97
GB - Regno Unito 83
HK - Hong Kong 80
FI - Finlandia 68
VN - Vietnam 32
IT - Italia 31
RU - Federazione Russa 29
IE - Irlanda 24
FR - Francia 23
TR - Turchia 23
IN - India 17
CA - Canada 15
IR - Iran 10
PL - Polonia 10
MX - Messico 8
SE - Svezia 7
JP - Giappone 6
AR - Argentina 5
BD - Bangladesh 5
ZA - Sudafrica 5
BE - Belgio 4
ES - Italia 4
LT - Lituania 4
MA - Marocco 4
AT - Austria 3
AZ - Azerbaigian 3
SK - Slovacchia (Repubblica Slovacca) 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
EC - Ecuador 2
EU - Europa 2
HN - Honduras 2
IQ - Iraq 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LV - Lettonia 2
NL - Olanda 2
PK - Pakistan 2
UZ - Uzbekistan 2
AL - Albania 1
BH - Bahrain 1
CL - Cile 1
DZ - Algeria 1
ET - Etiopia 1
GE - Georgia 1
GR - Grecia 1
IL - Israele 1
JO - Giordania 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PE - Perù 1
PH - Filippine 1
QA - Qatar 1
SA - Arabia Saudita 1
SY - Repubblica araba siriana 1
TM - Turkmenistan 1
TW - Taiwan 1
UY - Uruguay 1
Totale 3.336
Città #
Woodbridge 218
Fairfield 204
Ashburn 191
Ann Arbor 131
Singapore 130
Houston 117
Jacksonville 116
Chandler 102
Hong Kong 80
Cambridge 77
Beijing 75
Seattle 74
Wilmington 71
Nanjing 49
Los Angeles 46
Helsinki 43
Princeton 42
New York 39
Lancaster 37
Munich 31
Dublin 24
The Dalles 24
Istanbul 21
Shanghai 18
Nanchang 17
Jinan 16
Shenyang 16
Des Moines 14
Tianjin 14
Changsha 13
Ho Chi Minh City 12
San Diego 12
Moscow 11
San Francisco 11
Santa Clara 11
Ardabil 10
São Paulo 10
Dallas 9
Hebei 9
Milan 9
Warsaw 9
Buffalo 8
London 8
Redondo Beach 8
Toronto 8
Phoenix 7
Dearborn 6
Frankfurt am Main 6
Hanoi 6
Kunming 6
Turku 6
Washington 6
Hangzhou 5
Ningbo 5
Stockholm 5
Tokyo 5
Atlanta 4
Augusta 4
Brussels 4
Chicago 4
Curitiba 4
Lanzhou 4
Monmouth Junction 4
Poplar 4
Porto Alegre 4
Rio de Janeiro 4
Baku 3
Biên Hòa 3
Bratislava 3
Brescia 3
Brooklyn 3
City of London 3
Da Nang 3
Fuzhou 3
Guangzhou 3
Haikou 3
Johannesburg 3
Mexico City 3
Montreal 3
Nuremberg 3
Querétaro 3
Taiyuan 3
Belo Horizonte 2
Bishkek 2
Boston 2
Campinas 2
Changchun 2
Charlotte 2
Chennai 2
Conselheiro Lafaiete 2
Denver 2
Düsseldorf 2
Hefei 2
Hải Dương 2
Jiaxing 2
Kansas City 2
Lahore 2
Leawood 2
Maricá 2
New Delhi 2
Totale 2.382
Nome #
The Disagreement Among Methods to Evaluate Glomerular Filtration Rate in HIV-Infected Patients Naive to Antiretroviral Therapy. 220
Cohort profile: Standardized management of antiretroviral therapy cohort (MASTER cohort) 207
No evidence of relation between peripheral neuropathy and presence of hemochromatosis gene mutations in HIV-1-positive patients. 161
Dideoxynucleoside HIV reverse transcriptase inhibitors and drug-related hepatotoxicity: a case report. 158
Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational study 158
Prediction of early and confirmed virological response by genotypic inhibitory quotients for lopinavir in patients naive for lopinavir with limited exposure to previous protease inhibitors. 155
Influence of folate serum concentration on plasma homocysteine levels in HIV-positive patients exposed to protease inhibitors undergoing HAART. 153
Heterogeneity and penetration of HIV-1 non-subtype B viruses in an Italian province: public health implications. 152
Effectiveness of antiretroviral regimens containing abacavir with tenofovir in treatment-experienced patients: predictors of virological response and drug resistance evolution in a multi-cohort study. 149
Influence of viral chronic hepatitis co-infection on plasma drug concentrations and liver transaminase elevations upon therapy switch in HIV-positive patients. 148
Adherence and plasma drug concentrations are predictors of confirmed virologic response after 24-week salvage highly active antiretroviral therapy. 148
Risk of chronic kidney disease among patients developing mild renal impairment during tenofovir-containing antiretroviral treatment 147
Incidence and risk factors for liver enzyme elevation during highly active antiretroviral therapy in HIV-HCV co-infected patients: results from the Italian EPOKA-MASTER Cohort. 143
Hepatitis C virus antibody-positive patients with HIV infection have a high risk of insulin resistance: a cross-sectional study 140
Risk factors and clinical characteristics associated with hospitalization for community-acquired bacterial pneumonia in HIV-positive patients according to the presence of liver cirrhosis. 132
Hyperbilirubinemia during atazanavir treatment in 2,404 patients in the Italian atazanavir expanded access program and MASTER Cohorts 124
Plasma HIV load and proviral DNA decreases after two standard antiretroviral regimens in HIV-positive patients naïve to antiretrovirals 116
Analysis of severe hepatic events associated with nevirapine-containing regimens: CD4+ T-cell count and gender in hepatitis C seropositive and seronegative patients. 113
Adherence and plasma drug concentrations are predictors of confirmed virologic response after 24-week salvage highly active antiretroviral therapy 110
Influence of hepatitis C genotypes on lipid levels in HIV-positive patients during highly active antiretroviral therapy. 107
Influence of genotype 3 hepatitis C coinfection on liver enzyme elevation in HIV-1-positive patients after commencement of a new highly active antiretroviral regimen: results from the EPOKA-MASTER Cohort. 105
Long-term durability of tenofovir-based antiretroviral therapy In relation to the Co-administration of other drug classes in routine clinical practice 94
Predictors of AIDS-defining events among advanced naïve patients after HAART. 93
Predictors of clinical progression among HIV-1-positive patients starting HAART with CD4+ T-cell counts > or =200 cells/mm3. 90
Influence of efavirenz and 8-hydroxy-efavirenz plasma levels on cognition and central nervous system side effects 40
Totale 3.363
Categoria #
all - tutte 14.016
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.016


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021223 0 0 0 0 0 53 14 38 47 27 30 14
2021/2022221 34 21 5 10 0 12 7 16 5 30 22 59
2022/2023247 23 5 6 14 25 61 0 29 56 1 10 17
2023/2024245 11 7 25 32 12 48 13 6 55 13 4 19
2024/2025487 8 6 1 68 54 38 32 27 51 48 97 57
2025/2026573 93 93 43 117 158 69 0 0 0 0 0 0
Totale 3.363